Arginase promotes neointima formation in rat injured carotid arteries - Wikidata - wikimedia - TriplyDB

Arginase promotes neointima formation in rat injured carotid arteries

Arginase promotes neointima formation in rat injured carotid arteries

http://www.wikidata.org/entity/Q37143923

about

Aging and the control of human skin blood flow Piceatannol-3'-O-beta-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity.Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival.OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration.Tolerance-inducing strategies in islet transplantation Arginase inhibition attenuates arteriogenesis and interferes with M2 macrophage accumulation.Activation of AMP-activated protein kinase inhibits the proliferation of human endothelial cells.Role of arginase in vessel wall remodeling.Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats Experimental Rat and Mouse Carotid Artery Surgery: Injury & Remodeling Studies.Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction.Peripheral mechanisms of thermoregulatory control of skin blood flow in aged humans Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?Therapeutic strategies for endothelial dysfunction.Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.Obesity-induced vascular inflammation involves elevated arginase activity.Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II.Arginase Inhibition Suppresses Native Low-Density Lipoprotein-Stimulated Vascular Smooth Muscle Cell Proliferation by NADPH Oxidase Inactivation.Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression

P2860

Q28394291-CDCB957D-04E5-4D9B-96B8-201DE8DA02DC Q34029838-5FA7C75E-BA69-4390-BE53-C573E8684FDF Q34308232-D2A19107-1E9B-49F4-9A75-AAA146B9E2EB Q34502017-B2BDA913-4847-41C9-AA88-4E47E11DF301 Q34543359-E5AFED68-EB21-4A05-8C8B-CC27E208FCAC Q34755179-A3C19B3E-405B-4BB9-858C-DD78EE282416 Q35122850-8223C192-FEA1-4AB8-9231-F8B1383B66CD Q35217395-5CC8E9F8-EDFB-4C22-8104-29526A9AF602 Q35845518-78D96665-5E48-4F7A-9806-8C622A655D5C Q36004707-C212FF08-38B5-4442-89F4-70C40A77F200 Q36033820-13FF3A7A-9301-4557-93B4-98A66D650FA3 Q36174159-0A534F54-1960-4298-B5A7-6CACB2B7694A Q36837617-502D65DA-7B88-4133-9210-9F5EB8CEC0A9 Q36854784-008DA6DD-D301-4D93-B700-8B9A66E35A49 Q36916621-FDC63CA9-96C4-4C27-BA8C-E7BFB11C8F9F Q36973472-5349D390-D568-4909-B4DF-D0C971615171 Q37174305-DB7FF090-7C35-416A-A975-4D46EEA8F6D2 Q38082329-EC0B5CAE-F20E-4FD1-87BB-0A2DBA6513B8 Q46470925-3AA27BB6-142A-4D96-9CC4-6D74294220D0 Q47734746-46D46721-D2A2-418C-869D-6F44802DE5CC Q47789699-E22B242B-4D3E-4B4C-86D1-9D1263BEC325 Q51376719-585489BA-EE80-4DB9-BF8C-9EA34BC0D65C Q52610853-04CE87AA-8C38-445E-A1FF-7A5D12C00811 Q57491629-2349C86E-2B21-4821-B024-F4E5B249BB91

P2860

Arginase promotes neointima formation in rat injured carotid arteries

http://www.wikidata.org/entity/Q37143923

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Arginase promotes neointima formation in rat injured carotid arteries

@en

Arginase promotes neointima formation in rat injured carotid arteries.

@nl

type

label

Arginase promotes neointima formation in rat injured carotid arteries

@en

Arginase promotes neointima formation in rat injured carotid arteries.

@nl

prefLabel

Arginase promotes neointima formation in rat injured carotid arteries

@en

Arginase promotes neointima formation in rat injured carotid arteries.

@nl

P1433

Q37143923-8EF5DD26-A9F9-455E-B63B-402FB631D9C3

P1476

Q37143923-F8A6DAEF-8FC2-4118-93F8-E7A359090AAD

P2093

Q37143923-193C87B0-4437-4FCB-AECD-9AE51523EF5E

Q37143923-373923D3-452F-4C13-8ACE-434FB9418E80

Q37143923-60FDD474-A00C-4D1E-AD74-F3348166D126

Q37143923-74A1CD03-F69B-4B00-A75A-D7C4509A1C5C

Q37143923-92219F80-494B-4C33-870E-62324447EA4D

Q37143923-AB1671EF-DEB6-441A-B212-1C99188CBA2B

Q37143923-B0D5BC6B-051E-4EFB-BBF6-3C2AC9567B00

Q37143923-DDF30994-46CC-44B5-AEE3-9C6D66D87C19

Q37143923-F6EEBC7E-B1FC-49BA-A736-9345C9EE92FD

P2860

Q37143923-0138EB10-1665-49A9-AFE1-B7DA3903BC5F

Q37143923-016CB5B9-4968-4DC2-9A12-BF61775089C5

Q37143923-16A5AE45-1148-4FCB-97A7-F441F0DED57B

Q37143923-17ACD7F6-F881-4788-90BD-662C71627A6A

Q37143923-1B3D451D-FC8C-4623-8524-81264F805E79

Q37143923-22F32130-08F2-4496-9E56-C2F494DBE546

Q37143923-25AAB540-24B1-48CF-967F-AAB9DE801F3E

Q37143923-27471003-4DDA-4D83-AF4F-6A87DA9AB618

Q37143923-2C893AE3-F524-44F0-87C2-EC7527C25363

Q37143923-33A8E3C7-6705-4773-A336-06BBE46B7358

P304

Q37143923-0B1DDCD4-89BE-43D4-8534-272471991142

P31

Q37143923-F25B19EE-E3E5-4475-8A7C-D5CFCF19E16A

P356

Q37143923-6F79CE3B-EB6B-4668-A7A2-888BC077DEAC

P407

Q37143923-59E6D48B-9EC9-49EE-8298-6C26ACC7BE09

P433

Q37143923-BAF2A08D-1223-49BD-BAF6-38FBAB52EEF5

P478

Q37143923-9A29B3D9-9FF8-4F0D-981F-83AC28372DD1

P577

Q37143923-E7700B09-D2FE-4CC0-A134-8A5828CECA0E

P698

Q37143923-7E07CC00-2F96-42D0-B711-967BD015536C

P932

Q37143923-EE6F0891-8D3F-444B-9B3F-DBD6C7223D14

P356

ATVBAHA.108.183392

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Arginase promotes neointima formation in rat injured carotid arteries

@en

P2093

Amit N Keswani

http://www.w3.org/2001/XMLSchema#string

David A Tulis

http://www.w3.org/2001/XMLSchema#string

Diana Ensenat

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Kelly J Peyton

http://www.w3.org/2001/XMLSchema#string

Mohammed A Azam

http://www.w3.org/2001/XMLSchema#string

Sankaranarayanan Kannan

http://www.w3.org/2001/XMLSchema#string

William Durante

http://www.w3.org/2001/XMLSchema#string

Xiao-ming Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation

Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells

Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries

Activities of arginase I and II are limiting for endothelial cell proliferation

Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis.

Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries.

Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells.

Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation.

P304

488-494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.108.183392

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19164802

http://www.w3.org/2001/XMLSchema#string

P932

2662760

http://www.w3.org/2001/XMLSchema#string